Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 4, 2007, Pages 395-400

  Teh, Bin S ^a,b   Bastasch, Michael D ^a   Mai, Wei Yuan ^a   Kadmon, Dov ^a   Miles, Brian J ^a   Butler, E Brian ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUPRORELIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORPUS CAVERNOSUM; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NERVE GRAFT; PENIS ERECTION; POSTOPERATIVE CARE; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; SURAL NERVE;

AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MIDDLE AGED; PENILE ERECTION; PENIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SURAL NERVE; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 34548382598     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318033728f     Document Type: Article

References (38)

1. Kim ED, Nath R, Slawin KM, et al. Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up. Urology. 2001;58:983-987.
2. Ponholzer A, Brossner C, Struhal G, et al. Lower urinary tract symptoms, urinary incontinence, sexual function and quality of life after radical prostatectomy and external beam radiation therapy: real life experience in Austria. World J Urol. 2006;24:325-330.
3. Gralnek D, Wessells H, Cui H, et al. Differences in sexual function and quality of life after nerve-sparing and nonnerve-sparing radical retropubic prostatectomy. J Urol. 2000;163:1166-1169; discussion 1169-1170.
4. Walsh PC, Mostwin JL. Radical prostatectomy and cystoprostatectomy with preservation of potency: results using a new nerve-sparing technique. Br J Urol. 1984;56:694-697.
5. Catalona WJ, Carvalhal GF, Mager DE, et al. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol. 1999;162:433-438.
6. Catalona WJ, Basler JW. Return of erections and urinary continence following nerve-sparing radical retropubic prostatectomy. J Urol. 1993;150:905-907.
7. Quinlan DM, Epstein JI, Carter BS, et al. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol. 1991;145:998-1002.
8. Noldus J, Michl U, Graefen M, et al. Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. Eur Urol. 2002;42:118-124.
9. Rabbani F, Stapleton AM, Kattan MW, et al. Factors predicting recovery of erections after radical prostatectomy. J Urol. 2000;164:1929-1934.
10. Kim ED, Scardino PT, Hampel O, et al. Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy. J Urol. 1999;161:188-192.
11. Kim ED, Nath R, Kadmon D, et al. Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup. J Urol. 2001;165:1950-1956.
12. Teh BS, Bastasch MD, Mai WY, et al. Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins. J Urol. 2006;175:2097-2101; discussion 2101-2092.
13. Stephenson AJ, Eastham JA. Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol. 2005;23:8198-8203.
14. Swanson GP, Thompson IM Jr, Tangen C, et al. Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SWOG 8794). Int J Radiat Oncol Biol Phys. 2005;63(suppl 1):1.
15. Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet. 2005;366:572-578.
16. Brown PD, Eshleman JS, Foote RL, et al. An analysis of facial nerve function in irradiated and unirradiated facial nerve grafts. Int J Radiat Oncol Biol Phys. 2000;48:737-743.
17. Pavy JJ, Denekamp J, Letschert J, et al. EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys. 1995;31:1043-1047.
18. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822-830.
19. Teh BS, Mai WY, Augspurger ME, et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys. 2001;49:465-472.
20. McGary JE, Grant W 3rd. A clinical evaluation of setup errors for a prostate immobilization system. J Appl Clin Med Phys. 2000;1:138-147.
21. Michl UH, Friedrich MG, Graefen M, et al. Prediction of postoperative sexual function after nerve-sparing radical retropubic prostatectomy. J Urol. 2006;176:227-231.
22. Zelefsky MJ, Aschkenasy E, Kelsen S, et al. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1997;39:327-333.
23. Zelefsky MJ, Eid JF. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys. 1998;40:129-133.
24. al-Abany M, Steineck G, Agren Cronqvist AK, et al. Improving the preservation of erectile function after external beam radiation therapy for prostate cancer. Radiother Oncol. 2000;57:201-206.
25. Wilder RB, Chou RH, Ryu JK, et al. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results. Am J Clin Oncol. 2000;23:330-333.
26. Chang DW, Wood CG, Kroll SS, et al. Cavernous nerve reconstruction to preserve erectile function following non-nerve-sparing radical retropubic prostatectomy: a prospective study. Plast Reconstr Surg. 2003;111:1174-1181.
27. Kim ED, Scardino PT, Kadmon D, et al. Interposition sural nerve grafting during radical retropubic prostatectomy. Urology. 2001;57:211-216.
28. Millesi H. Healing of nerves. Clin Plast Surg. 1977;4:459-473.
29. Evans GR, Brandt K, Ang KK, et al. Peripheral nerve regeneration: the effects of postoperative irradiation. Plast Reconstr Surg. 1997;100:375-380.
30. Brandt K, Evans GR, Ang KK, et al. Postoperative irradiation: are there long-term effects on nerve regeneration? J Reconstr Microsurg. 1999;15:421-425.
31. McGuirt WF, Welling DB, McCabe BF. Facial nerve function following irradiated cable grafts. Laryngoscope. 1989;99:27-34.
32. Conley JJ. Facial rehabilitation following radical parotid-gland surgery. AMA Arch Otolaryngol. 1957;66:58-66.
33. McGuirt WF, McCabe BF. Effect of radiation therapy on facial nerve cable autografts. Laryngoscope. 1977;87:415-428.
34. Lathrop FD. Benign tumors of the parotid gland: a twenty-five year review. Laryngoscope. 1962;72:992-1006.
35. Pillsbury HC, Fisch U. Extratemporal facial nerve grafting and radiotherapy. Arch Otolaryngol. 1979;105:441-446.
36. Catalona WJ, Bigg SW. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol. 1990;143:538-543; discussion 544.
37. Merrick GS, Wallner K, Butler WM, et al. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys. 2001;50:597-604.
38. Fisch BM, Pickett B, Weinberg V, et al. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology. 2001;57:955-959.